Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1408.839
  • +21.455+1.55%
Close May 31 16:00 ET
1412.417High1387.973Low
Constituent Stocks: 10Top Rising: SGMO+3.49%
Intraday
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
SGMOSangamo Therapeutics
0.5640.019+3.52%1.33M738.51K0.5400.5450.5800.533117.12M96.56M207.51M171.09M-8.66%-7.28%+8.12%-44.12%+23.37%-50.92%+3.88%--0.78%LossLoss8.69%Biotechnology
VRTXVertex Pharmaceuticals
455.34012.290+2.77%2.36M1.07B444.740443.050456.910443.470117.50B117.15B258.05M257.28M+1.01%+3.34%+13.79%+10.56%+28.65%+36.42%+11.91%--0.92%29.5532.783.03%Biotechnology
CRBUCaribou Biosciences
2.8800.030+1.05%1.47M4.26M2.9102.8502.9802.860260.12M198.81M90.32M69.03M-4.32%-19.78%-20.88%-61.13%-51.60%-39.87%-49.74%--2.13%LossLoss4.21%Biotechnology
BLUEbluebird bio
0.9030.008+0.87%4.17M3.81M0.9000.8960.9440.890174.12M173.35M192.74M191.88M-6.79%-13.96%+0.01%-37.70%-81.22%-75.11%-34.54%--2.18%LossLoss6.05%Biotechnology
EDITEditas Medicine
5.2000.030+0.58%2.43M12.73M5.1905.1705.4205.160427.64M396.92M82.24M76.33M-10.81%-11.71%-7.47%-42.73%-52.29%-46.23%-48.67%--3.18%LossLoss5.03%Biotechnology
CRSPCRISPR Therapeutics
53.740-0.320-0.59%1.12M60.22M54.26054.06054.73553.3804.56B4.48B84.92M83.38M-3.57%-3.47%-2.42%-33.51%-23.46%-17.32%-14.15%--1.34%LossLoss2.51%Biotechnology
AAgilent Technologies
130.410-1.010-0.77%5.33M699.51M131.000131.420134.065129.56038.03B37.88B291.59M290.45M-13.38%-15.49%-5.17%-10.67%+1.68%+11.12%-6.05%0.71%1.84%30.9031.123.43%Diagnostics & Research
BEAMBeam Therapeutics
23.820-0.270-1.12%948.78K22.63M24.13024.09024.40223.5801.96B1.82B82.31M76.49M-0.79%+0.13%+4.84%-37.77%-17.15%-30.00%-12.49%--1.24%LossLoss3.41%Biotechnology
NTLAIntellia Therapeutics
21.380-0.720-3.26%1.95M41.98M22.33022.10022.56421.3102.06B2.04B96.48M95.33M-14.07%-18.30%-8.12%-28.61%-28.21%-47.80%-29.88%--2.04%LossLoss5.67%Biotechnology
APLSApellis Pharmaceuticals
39.250-1.500-3.68%2.00M78.94M40.03040.75040.63038.3504.76B3.21B121.37M81.70M-1.08%-6.55%-17.35%-35.59%-38.71%-55.38%-34.43%--2.45%LossLoss5.60%Biotechnology

News

Comments

Read more